Nation’s Independent Long Term Care Pharmacies Commend Administration for Nomination of Alex Azar II for Secretary of the U.S. Department of Health and Human Services (HHS)
Washington, DC – The Senior Care Pharmacy Coalition (SCPC) – the leading non-profit advocacy organization dedicated to representing the exclusive legislative and regulatory interests of independent long term care (LTC) pharmacies and the vulnerable patients they serve – today commended President Trump for his nomination of Alex Azar for Secretary of the Department of Health and Human Services (HHS).
SCPC pointed to Azar’s deep understanding of the healthcare sector and experience from both the private and public side of the industry, including the Medicare and Medicaid programs that are so essential to the millions of seniors and vulnerable Americans who rely upon them for their care. Mr. Azar’s experience is crucial to striking a balance to protect and improve the integrity of the nation’s healthcare system.
“Mr. Azar has a reputation for data-driven, bipartisan policy solutions that improve patient care and safety, while improving efficiencies, such as the reduction of hospital admissions,” said Alan Rosenbloom, CEO of SCPC. “SCPC remains supportive of and hopeful for an expeditious confirmation so we may work collaboratively to address important issues ranging from improving patient care to reducing the financial burdens on seniors and our healthcare system. To do so, we look forward to working with Mr. Azar to uncover and eliminate the oligopolistic and ant-competitive pricing and market practices of secretive Pharmacy Benefit Managers (PBMs), which are putting patient care at risk and driving up prescription drug costs to consumers and the Medicare program.”
####
The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities across the country occupying approximately 675,000 beds. Visit us at www.seniorcarepharmacies.org to learn more.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.